​

Funding Round

Series C - Rodin Therapeutics

Series C - Rodin Therapeutics

Investment Firm

Overview

Rodin Therapeutics develops novel therapeutics for neurological disorders by applying insights of epigenetics.

Announced Date

Sep 18, 2017

Funding Type

Series C

Highlights

Location

United States, North America

Social

Investor Lead

Atlas Venture

Atlas Venture

Atlas Venture is a early_stage_venture and late_stage_venture and post_ipo and seed and venture firm.

Participant Investors

5

Investor Name
Participant InvestorRemeditex Ventures
Participant InvestorHatteras Venture Partners
Participant InvestorAtlas Venture
Participant InvestorGoogle Ventures
Participant InvestorThird Point Ventures

Round Details and Background

Rodin Therapeutics raised $27000000 on 2017-09-18 in Series C

Rodin Therapeutics develops novel therapeutics for neurological disorders by applying insights of epigenetics.

Company Funding History

4

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Sep 18, 2017
Series C - Rodin Therapeutics
6-27.0M
Jan 06, 2016
Series B - Rodin Therapeutics
2-17.3M
May 29, 2014
Series A - Rodin Therapeutics
2-12.9M
Jun 27, 2013
Seed Round - Rodin Therapeutics
2-undefined

Recent Activity

There is no recent news or activity for this profile.